$68.54 0.29 (0.42%)
19:37 EDT ABBV Stock Quote Delayed 15 Minutes
Previous Close $68.54
Market Cap 108.76B
PE Ratio 17.22
Volume (Avg. Vol.) 9.81M
Day's Range 68.10 - 68.82
52-Week Range 65.06 - 100.23
Dividend & Yield 3.59 (5.24%)
ABBV Stock Predictions, Articles, and AbbVie News
- From InvestorPlace
- From the Web
Some of the highest-yielding dividend stocks are actually bargains in the making. Here are five that have great prospects, cash flows, and profits to keep their high yields going.
This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.
Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.
Options trading was buzzing in AbbVie, FedEx and Micron Tuesday. Here are the metrics that matter moving forward.
The stock charts of TSN, STT and LEN are headed into the midpoint of the week on the verge of major turns.
Biotech rallied on a $63 billion deal between AbbVie and Allergan. But other than that, it was a tough day for the Nasdaq today.
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
These biopharma stocks could be perfect stocks to buy for those looking at the long term or for anyone looking for strong dividend stocks.
News of an AbbVie-Allergan deal has AGG stock heading higher on Tuesday with plans for the former company to acquire the latter.
The stock charts of Medtronic, Paychex and AbbVie are poised to get the new trading week started with a bang.
MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.
Play a friendly and widening price spread in biotech stocks with a well-place purchase in Merck and an equally smart short in AbbVie.
The stock charts of COP, MGM and ABBV stock are moving into pivotal positions as the trading week winds down.
High yield doesn't always have to entail extreme risk, especially with these viable dividend stocks to buy.
AbbVie stock's been fairly awful lately as its core drug is showing signs of slowing down. Yet ABBV stock should not be ignored since there’s a bit of a cannabis play here.
Although recreational weed captures headlines, the real money is on broadly accepted medicinal marijuana stocks.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!